Key result
Neuroleptic therapy unmasks Brugada pattern, highlighting the need for regular ECG monitoring.
Case Report (n=1)
No
Highlights the potential for neuroleptics to induce Brugada syndrome, emphasizing the importance of regular ECG monitoring in patients on psychotropic medications.
Brugada syndrome is a rare genetic disease, of autosomal dominant inheritance with low penetrance, manifested by ST-segment elevation at right precordial V1, V2, and V3, and right branch block aspect. to the electrocardiogram. It exposes to a high risk of ventricular arrhythmia that can cause syncope and even sudden death, on a structurally healthy heart.We report here the case of a young patient of 25 years who has a syndrome of Brugada induced by a neuroleptic. To our knowledge, this is the first reported case of Brugada syndrome induced by a neuroleptic Morocco. Therapeutic management is based on Amiodarone and beta-blockers. Regular monitoring of the ECG should, however, be performed on patients taking psychotropic drugs and also on associations.
No takes yet. Share an insight, caveat, or question.
Laboudi et al. (2018) conducted a case report in Neuroleptic-Induced Brugada Syndrome (n=1). Neuroleptic was evaluated. A 25-year-old patient developed Brugada syndrome induced by a neuroleptic, highlighting the need for regular ECG monitoring in patients taking psychotropic drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: